Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the REDEFINE 1 trial, people who stayed on treatment lost an average of 22.7% of their body weight
This suggests that, at higher dose ranges, switching between agents may provide incremental benefit beyond within-drug dose escalation in selected patients
Researchers are encouraged to verify batch details before commencing laboratory work
Related reading: The connection between diabetes and heart disease What are the risks and side effects to consider
ReadyRx Sermorelin Program Overview For individuals who, after consulting with a licensed clinician, are determined to be appropriate candidates for Sermorelin therapy, ReadyRx coordinates access through its telehealth model
This work was supported by the National Natural Scientific Foundation of China [82202950, 82072943, and 82072929]
US$ 27.61
US$ 28.13
US$ 21.94
US$ 27.22
US$ 24.87
